• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    FACT II Acquisition Corp. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    7/21/26 4:33:07 PM ET
    $FACT
    Get the next $FACT alert in real time by email
    false 0002028935 00-0000000 0002028935 2026-07-16 2026-07-16 0002028935 FACT:UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001PerShareAndOnehalfOfOneRedeemableWarrantMember 2026-07-16 2026-07-16 0002028935 FACT:ClassOrdinarySharesParValue0.0001PerShareIncludedAsPartOfUnitsMember 2026-07-16 2026-07-16 0002028935 FACT:WarrantsIncludedAsPartOfUnitsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50Member 2026-07-16 2026-07-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): July 16, 2026

     

    FACT II ACQUISITION CORP.

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   001-42421   N/A

    (State or other jurisdiction of

    incorporation or organization)

      (Commission File Number)  

    (IRS Employer

    Identification Number)

     

    14 Wall Street, 20th Floor

    New York, New York

    United States of America

      10005
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (212) 618-1798

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class  

    Trading Symbol(s)

     

    Name of each exchange on which registered

    Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant   FACTU   Nasdaq Global Market
    Class A ordinary shares, par value $0.0001 per share, included as part of the units   FACT   Nasdaq Global Market
    Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   FACTW   Nasdaq Global Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

    Item 1.02 Termination of a Material Definitive Agreement.

     

    Business Combination Agreement

     

    As previously disclosed, FACT II Acquisition Corp., a Cayman Islands exempted company (“FACT”), entered into a Business Combination Agreement, dated as of November 26, 2025, as amended by Amendment No. 1 thereto dated as of May 17, 2026 (the “Business Combination Agreement”), by and among FACT, FACT II Acquisition LLC, a Cayman Islands limited liability company (“Sponsor HoldCo”), Patriot Merger Subsidiary, Inc., a Florida corporation and a wholly-owned subsidiary of FACT, and Precision Aerospace & Defense Group, Inc., a Florida corporation (“PAD”).

     

    On July 16, 2026, the Business Combination Agreement was terminated in accordance with the terms set forth therein (the “Termination”).  

     

    Sponsor Support Agreement

     

    As previously disclosed, on November 26, 2025, Sponsor HoldCo entered into a voting and support agreement with FACT and PAD (the “Sponsor Support Agreement”) in connection with the Business Combination Agreement.

     

     As a result of the Termination, the Sponsor Support Agreement terminated in accordance with its respective terms.

     

    PAD Support Agreements

     

    As previously disclosed, on January 6, 2026 and January 19, 2026, PAD, FACT and certain stockholders of PAD entered into support agreements (collectively, the “PAD Support Agreements”) in connection with the Business Combination Agreement.

     

     As a result of the Termination, the PAD Support Agreements terminated in accordance with their respective terms.

     

    Item 7.01 Regulation FD Disclosure.

     

    On July 21, 2026, FACT issued a press release announcing the termination of the Business Combination Agreement. A copy of the press release is furnished hereto as Exhibit 99.1 hereto.

     

    The information in this Item 7.01 and Exhibit 99.1 is being furnished pursuant to Item 7.01 and will not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liabilities of that section, nor will it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d)Exhibits

     

    Exhibit No.   Description
    99.1   Press Release, dated July 21, 2026.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

    1

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: July 21, 2026

     

      FACT II ACQUISITION CORP.
       
     

    By:

    /s/ Adam Gishen

      Name: Adam Gishen
      Title: Chief Executive Officer

     

    2

     

    Get the next $FACT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FACT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FACT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FACT II Acquisition Corp. Announces Termination of Proposed Business Combination with Precision Aerospace & Defense Group, Inc.

    New York, NY, July 21, 2026 (GLOBE NEWSWIRE) --  FACT II Acquisition Corp. ("FACT II"), a special purpose acquisition company, announced today that the previously announced Business Combination Agreement with Precision Aerospace & Defense Group, Inc. ("PAD") has been terminated. Adam Gishen, Chief Executive Officer of FACT II, noted: "Throughout this process, we worked diligently to assemble the capital required to complete the transaction and were pleased to have received multiple financing proposals on favorable market terms that would have in aggregate exceeded the minimum cash condition of $75 million as set forth in the Business Combination Agreement. Unfortunately, the unforeseen c

    7/21/26 4:15:00 PM ET
    $FACT

    Correction: Precision Aerospace & Defense Group Announces Letter of Intent with Leader in Communications, Security and Surveillance Integration Solutions

    Proposed Strategic Acquisition Represents a Major Industry Expansion as Company Advances Toward Public Listing Overland Park, KS, June 09, 2026 (GLOBE NEWSWIRE) -- Precision Aerospace & Defense Group, Inc. ("PAD" or the "Company"), a high-growth aerospace and defense engineering and manufacturing company, today announced its entry into a non-binding Letter of Intent to acquire a leading provider of telecommunications equipment, surveillance systems, and structural steel fabrication defense applications ("Target"). The announcement follows the Company's previously disclosed proposed business combination with FACT II Acquisition Corp. ("FACT") (NASDAQ:FACT), a special purpose acquisition c

    6/9/26 4:15:00 PM ET
    $FACT

    Precision Aerospace & Defense Group Announces Letter of Intent with Leader in Communications, Security and Surveillance Integration Solutions

    Proposed Strategic Acquisition Represents a Major Industry Expansion as Company Advances Toward Public Listing Overland Park, KS, June 05, 2026 (GLOBE NEWSWIRE) -- Precision Aerospace & Defense Group, Inc. ("PAD" or the "Company"), a high-growth aerospace and defense engineering and manufacturing company, today announced its entry into a non-binding Letter of Intent to acquire a leading provider of telecommunications equipment, surveillance systems, and structural steel fabrication defense applications ("Target"). The announcement follows the Company's previously disclosed proposed business combination with FACT II Acquisition Corp. ("FACT") (NASDAQ:FACT), a special purpose acquisition co

    6/5/26 6:20:00 AM ET
    $FACT

    $FACT
    SEC Filings

    View All

    FACT II Acquisition Corp. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FACT II Acquisition Corp. (0002028935) (Filer)

    7/21/26 4:33:07 PM ET
    $FACT

    SEC Form 425 filed by FACT II Acquisition Corp.

    425 - FACT II Acquisition Corp. (0002028935) (Subject)

    6/9/26 4:40:57 PM ET
    $FACT

    SEC Form 425 filed by FACT II Acquisition Corp.

    425 - FACT II Acquisition Corp. (0002028935) (Subject)

    6/5/26 4:02:42 PM ET
    $FACT

    $FACT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: New insider Fact Ii Acquisition Llc claimed ownership of 440,000 units of Class A ordinary shares (SEC Form 3)

    3/A - FACT II Acquisition Corp. (0002028935) (Issuer)

    2/14/25 4:58:08 PM ET
    $FACT

    SEC Form 3 filed by new insider Fact Ii Acquisition Llc

    3 - FACT II Acquisition Corp. (0002028935) (Issuer)

    11/25/24 9:58:18 PM ET
    $FACT

    SEC Form 3 filed by new insider Rackind Robert

    3 - FACT II Acquisition Corp. (0002028935) (Issuer)

    11/25/24 9:56:28 PM ET
    $FACT

    $FACT
    Financials

    Live finance-specific insights

    View All

    Complete Solaria, an Industry-Leading Solar Services, Financing and Products Company, to Publicly List on NYSE through Business Combination with Freedom Acquisition I Corp.

    Complete Solaria has entered into a definitive business combination agreement with Freedom Acquisition I Corp. (NYSE:FACT) ("Freedom"). Upon closing of the business combination, which is expected in the first half of 2023, the combined Company is expected to be listed on the New York Stock Exchange under the new ticker "CSLR". Complete Solaria brings together two highly complementary businesses in a vertically integrated manufacturing and distribution model, delivering end to end residential solar solutions, world-class customer service, aesthetically appealing, high-performance solar panels, as well as project financing, design and software solutions, to the U.S.A and beyond. Complete

    10/3/22 9:09:00 AM ET
    $FACT

    $FACT
    Leadership Updates

    Live Leadership Updates

    View All

    Complete Solaria Appoints Industry Veteran Brian Wuebbels as Chief Financial Officer

    Complete Solaria, Inc. ("Complete Solaria" or the "Company"), a leading solar technology, services, and installation company, today announced that Brian Wuebbels has been named Chief Financial Officer, effective February 1, 2023. Wuebbels brings more than 20 years of financial and executive experience, having served as CFO and in senior leadership positions for public and private solar and industrial companies throughout his career, including companies such NIDEC, GCL Solar Materials, SunEdison, Honeywell, and General Electric. "I am pleased to welcome Brian to our leadership team," said Will Anderson, Complete Solaria CEO. "Brian's deep and extensive public and private company experience

    2/1/23 8:30:00 AM ET
    $FACT

    Apexigen Announces Appointment of Francis Sarena as Chief Operating Officer

    SAN CARLOS, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, today announced the appointment of Francis Sarena as Chief Operating Officer. Mr. Sarena will be responsible for leading strategic operations, driving business development, overseeing finance and investor relations and optimizing organizational functions. "We are thrilled to welcome Francis, an accomplished industry veteran, during this important phase of Apexigen's evolution," said Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer of Apexigen. "His deep biopharmaceut

    1/4/22 8:00:00 AM ET
    $FACT
    $FPRX
    $PDLI
    Major Pharmaceuticals
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $FACT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Freedom Acquisition I Corp. Cl A (Amendment)

    SC 13G/A - Complete Solaria, Inc. (0001838987) (Subject)

    2/14/24 4:05:45 PM ET
    $FACT

    SEC Form SC 13G/A filed by Freedom Acquisition I Corp. Cl A (Amendment)

    SC 13G/A - Complete Solaria, Inc. (0001838987) (Subject)

    2/12/24 1:05:15 PM ET
    $FACT

    SEC Form SC 13G filed by Freedom Acquisition I Corp. Cl A

    SC 13G - Complete Solaria, Inc. (0001838987) (Subject)

    9/22/23 4:22:56 PM ET
    $FACT